相似文献
1
Oral Prednisolone Versus Dexamethasone for the Treatment of Infantile Epileptic Spasms Syndrome: Current Status and Way Forward.
Ann Indian Acad Neurol. 2022 Sep-Oct;25(5):807. doi: 10.4103/aian.aian_751_22. Epub 2022 Oct 31.
2
Prednisolone or tetracosactide depot for infantile epileptic spasms syndrome? A prospective analysis of data embedded within two randomised controlled trials.
Eur J Paediatr Neurol. 2023 Jan;42:110-116. doi: 10.1016/j.ejpn.2022.12.007. Epub 2022 Dec 26.
3
Oral Dexamethasone versus Prednisolone for Management of Children with West Syndrome: An Open-Labeled Randomized Controlled Pilot Trial.
Ann Indian Acad Neurol. 2022 Sep-Oct;25(5):916-920. doi: 10.4103/aian.aian_481_22. Epub 2022 Oct 31.
4
Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
Lancet Child Adolesc Health. 2018 Oct;2(10):715-725. doi: 10.1016/S2352-4642(18)30244-X. Epub 2018 Aug 29.
5
Efficacy analysis of oral dexamethasone in the treatment of infantile spasms and infantile spasms related Lennox-Gastaut syndrome.
BMC Pediatr. 2023 May 23;23(1):255. doi: 10.1186/s12887-023-04062-6.
6
Treating Infantile Spasms with High-Dose Oral Corticosteroids: A Retrospective Review of 87 Children.
Pediatr Neurol. 2018 Oct;87:30-35. doi: 10.1016/j.pediatrneurol.2018.06.011. Epub 2018 Aug 3.
7
Addition of pyridoxine to prednisolone in the treatment of infantile spasms: A pilot, randomized controlled trial.
Neurol India. 2018 Mar-Apr;66(2):385-390. doi: 10.4103/0028-3886.227281.
8
The landscape of infantile epileptic spasms syndrome in South Asia: peculiarities, challenges, and way forward.
Lancet Reg Health Southeast Asia. 2023 Feb 28;12:100170. doi: 10.1016/j.lansea.2023.100170. eCollection 2023 May.
9
Epileptic spasms related to neuronal differentiation factor 2 (NEUROD2) mutation respond to combined vigabatrin and high dose prednisolone therapy.
BMC Neurol. 2022 Dec 9;22(1):461. doi: 10.1186/s12883-022-02992-9.
10
Temporal trends in the cost and use of first-line treatments for infantile epileptic spasms syndrome.
Epilepsia. 2023 Mar;64(3):630-640. doi: 10.1111/epi.17498. Epub 2023 Jan 31.
本文引用的文献
1
Oral Dexamethasone versus Prednisolone for Management of Children with West Syndrome: An Open-Labeled Randomized Controlled Pilot Trial.
Ann Indian Acad Neurol. 2022 Sep-Oct;25(5):916-920. doi: 10.4103/aian.aian_481_22. Epub 2022 Oct 31.
2
Translation, Adaptation, and Validation of Hindi version of Quality of Life of the Infant (QUALIN) for Use in Infants and Toddlers.
Indian J Pediatr. 2023 Feb;90(2):124-130. doi: 10.1007/s12098-022-04132-0. Epub 2022 Jul 27.
3
Epilepsy and Neurodevelopmental Outcomes in a Cohort of West Syndrome Beyond Two Years of Age.
Indian J Pediatr. 2022 Aug;89(8):765-770. doi: 10.1007/s12098-021-03918-y. Epub 2021 Oct 8.
4
Management practices for West syndrome in South Asia: A survey study and meta-analysis.
Epilepsia Open. 2020 Aug 11;5(3):461-474. doi: 10.1002/epi4.12419. eCollection 2020 Sep.
5
Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial.
Epilepsy Res. 2000 Dec;42(2-3):133-9. doi: 10.1016/s0920-1211(00)00170-4.
Zotero 插件